Skip to content

Clinical trials

Phase 3 Melanoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Clear all

159 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20026
20033
20043
20053
20064
20074
20084
20094
20107
20115
20126
20138
20144
20159
20167
20176
20186
20194
20203
20215
202210
202312
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Active, not recruiting25
Terminated22
Recruiting14
Unknown status14
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb18
National Cancer Institute (NCI)9
Merck Sharp & Dohme LLC8
Biocad5
Hoffmann-La Roche5
Novartis Pharmaceuticals5
European Organisation for Research and Treatment of Cancer - EORTC4
GlaxoSmithKline4
Amgen3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma159
Neoplasm Metastasis18
Skin Neoplasms17
Neoplasms12
Breast Neoplasms8
Brain Neoplasms5
Carcinoma, Renal Cell5
Carcinoma, Non-Small-Cell Lung4
Uterine Cervical Neoplasms4
Anus Neoplasms3

Trials

Showing 26 to 50 of 159. Each trial links to its page on Pharma Observatory.

59 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.